Skip to main content
Advertisement
  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Inclusion, Diversity, Equity, Anti-racism, & Social Justice (IDEAS)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Null Hypothesis
    • Patient Pages
    • Translations
    • Topics A-Z
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center

Advanced Search

Main menu

  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Inclusion, Diversity, Equity, Anti-racism, & Social Justice (IDEAS)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Null Hypothesis
    • Patient Pages
    • Translations
    • Topics A-Z
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center
  • Home
  • Articles
  • Issues

User menu

  • My Alerts
  • Log in

Search

  • Advanced search
Neurology Genetics
Home
A peer-reviewed clinical and translational neurology open access journal
  • My Alerts
  • Log in
Site Logo
  • Home
  • Articles
  • Issues

Share

December 2018; 4 (6) Clinical/Scientific NotesOpen Access

Variable penetrance of Andersen-Tawil syndrome in a family with a rare missense KCNJ2 mutation

Reem Deeb, Aravindhan Veerapandiyan, Rabi Tawil, Simona Treidler
First published October 25, 2018, DOI: https://doi.org/10.1212/NXG.0000000000000284
Reem Deeb
From the Department of Neurology (R.D.), SUNY Downstate Medical Center, Brooklyn; Department of Neurology (A.V., R.T.), University of Rochester Medical Center; and Department of Neurology (S.T.), Stony Brook School of Medicine, NY.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Aravindhan Veerapandiyan
From the Department of Neurology (R.D.), SUNY Downstate Medical Center, Brooklyn; Department of Neurology (A.V., R.T.), University of Rochester Medical Center; and Department of Neurology (S.T.), Stony Brook School of Medicine, NY.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rabi Tawil
From the Department of Neurology (R.D.), SUNY Downstate Medical Center, Brooklyn; Department of Neurology (A.V., R.T.), University of Rochester Medical Center; and Department of Neurology (S.T.), Stony Brook School of Medicine, NY.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Simona Treidler
From the Department of Neurology (R.D.), SUNY Downstate Medical Center, Brooklyn; Department of Neurology (A.V., R.T.), University of Rochester Medical Center; and Department of Neurology (S.T.), Stony Brook School of Medicine, NY.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Full PDF
Citation
Variable penetrance of Andersen-Tawil syndrome in a family with a rare missense KCNJ2 mutation
Reem Deeb, Aravindhan Veerapandiyan, Rabi Tawil, Simona Treidler
Neurol Genet Dec 2018, 4 (6) e284; DOI: 10.1212/NXG.0000000000000284

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Permissions

Make Comment

See Comments

Downloads
518

Share

  • Article
  • Figures & Data
  • Info & Disclosures
Loading

Andersen-Tawil syndrome is an autosomal dominant potassium channelopathy characterized by episodic flaccid muscle weakness (periodic paralysis), cardiac abnormalities (ventricular arrhythmias, prolonged QT interval, and prominent U waves), and characteristic skeletal features (low set ears, ocular hypertelorism, small mandible, fifth digit clinodactyly, syndactyly, short stature, scoliosis, and broad forehead).1 Mutations in the KCNJ2 gene on chromosome 17q23 are found in about 60% of the patients with Andersen-Tawil syndrome.2 In the absence of a genetic change in KCNJ2, diagnosis of Andersen-Tawil syndrome is established by the presence of well-defined clinical findings. The distinctive clinical triad of Andersen-Tawil syndrome is present in 60%–80% of patients with KCNJ2 mutations.1,2 KCNJ2 encodes the pore-forming subunit of an inward-rectifying potassium channel protein, Kir2.1, helping in skeletal and cardiac muscle resting membrane potential stabilization. Mutations in this gene cause loss of function and dominant-negative suppression effects on the Kir2.1 protein, leading to disruption of the cardiac and skeletal muscle excitability.2,3 KCNJ2 mutations in Andersen-Tawil syndrome affect multiple tissues and results in a wide phenotypic variability causing diagnostic difficulties and delay.2 We describe the varied clinical characteristics of Andersen-Tawil syndrome in a Caucasian family (mother and her 2 daughters) with a rare missense mutation in KCNJ2.

The 42-year-old mother presented with a 15-year history of episodes of periodic paralysis affecting her upper or lower extremities. In the absence of a clear diagnosis, she was treated with systemic steroids on multiple occasions for presumed polymyositis. At the age of 34 years, during the first trimester of her first pregnancy, she had an episode of paralysis associated with hypokalemia. The weakness recovered after potassium supplementation. Her 7-year-old daughter has episodic muscle weakness, cardiac involvement with premature ventricular contractions and prominent U wave, and distinctive skeletal features while the younger daughter has only skeletal features. Both daughters had normal birth and development. The clinical features of our patients are described in the figure. Targeted sequencing of the KCNJ2 gene showed a heterozygous missense mutation (c. 575C>T; p.Thr192Ile) in exon 2 in the mother and both daughters. The testing was based on identification of the same mutation in mother's 21-year-old niece who was noted to have prolonged QT interval during an evaluation for syncope. She also has short toes and syndactyly, but no reported episodic weakness. The mother's brother, an obligate carrier, is asymptomatic.

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure Clinical features and pedigree of patients

(A) Clinical features of patients. aLow dose extended release potassium due to history of daily muscle weakness; prophylactic acetazolamide in the peri-menstrual period as menstruation is a trigger for periodic paralysis in her. (B) Pedigree of patients. Black symbols denote family members affected with Andersen-Tawil syndrome with genetic confirmation. Patients described in this report are indicated by arrows.

The missense mutation of p.Thr192Ile found in our patients was previously reported in a single Taiwanese family with Andersen-Tawil syndrome.4 The proband was a 35-year-old woman with typical clinical triad of Andersen-Tawil syndrome and fixed extremity and truncal weakness. In addition, she was also noted to have pyramidal tract signs and major depression. Her 8-year-old son, who was also affected with Andersen-Tawil syndrome with long-QT syndrome and characteristic skeletal features, was identified to have learning disability. Authors of the study postulated that the atypical neuropsychiatric features noted in this family expand the phenotype of Andersen-Tawil syndrome.4 Such clinical features (pyramidal tract signs, depression, cognitive delay, and learning disability) were not noted in our patients.

The pathogenicity of the mutation p.Thr192Ile remains unproven in vitro. This missense mutation causes replacement of the amino acid threonine by isoleucine at codon 192. The amino acid substitution is predicted to be “probably damaging” by the polymorphism phenotyping tool (Polyphen-2).5 The p.Thr192 residue is located in the highly conserved region of the C-terminal intracellular domain of the Kir2.1 protein emphasizing its importance during evolution.4,–,6 Moreover, replacement of threonine at this position by another amino acid alanine (p.Thr192Ala) has been reported to be causative for Andersen-Tawil syndrome.6,7 We speculate that the heterozygous missense mutation affecting this highly conserved region is associated with the Andersen-Tawil syndrome phenotype in our patients. The kindred described in this report and the kindred that was previously described4 provide clinical evidence for pathogenicity of this rare missense mutation in KCNJ2. In addition, our kindred demonstrated the wide intra-familial variability in penetrance of the clinical triad seen in Andersen-Tawil syndrome.

We suggest that physicians should be aware of this rare clinical entity and its high phenotypic variability even within a family while evaluating patients with transient muscle weakness. The subtle clinical and characteristic electrocardiographic features can help with early recognition and treatment.

Study funding

No targeted funding reported.

Disclosure

R. Deeb and A. Veerapandiyan report no disclosures. R. Tawil has served on scientific advisory boards for Fulcrum Therapeutics and Acceleron Pharma; serves on the editorial board of the Journal of Neuromuscular Diseases; receives publishing royalties from Wiley-Blackwell; has been a consultant for Acceleron; and has received research support from Fulcrum Therapeutics, NIH, and the FSH Society. S. Treidler reports no disclosures. Full disclosure form information provided by the authors is available with the full text of this article at Neurology.org/NG.

Appendix 1 Author contributions

Table

Footnotes

  • Funding information and disclosures are provided at the end of the article. Full disclosure form information provided by the authors is available with the full text of this article at Neurology.org/NG.

  • The Article Processing Charge was funded by the authors.

  • Received July 10, 2018.
  • Accepted in final form September 25, 2018.
  • Copyright © 2018 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology.

This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND), which permits downloading and sharing the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.

References

  1. 1.↵
    1. Adam MP,
    2. Ardinger HH,
    3. Pagon RA, et al.
    1. Veerapandiyan A,
    2. Statland JM,
    3. Tawil R
    . Andersen-tawil syndrome. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews®. Seattle, WA: University of Washington; 1993.
  2. 2.↵
    1. Statland JM,
    2. Fontaine B,
    3. Hanna MG, et al
    . Review of the diagnosis and treatment of periodic paralysis. Muscle Nerve 2018;57:522–530.
    OpenUrl
  3. 3.↵
    1. Plaster NM,
    2. Tawil R,
    3. Tristani-Firouzi M, et al
    . Mutations in Kir2.1 cause the developmental and episodic electrical phenotypes of Andersen's syndrome. Cell 2001;105:511–519.
    OpenUrlCrossRefPubMed
  4. 4.↵
    1. Chan HF,
    2. Chen ML,
    3. Su JJ,
    4. Ko LC,
    5. Lin CH,
    6. Wu RM
    . A novel neuropsychiatric phenotype of KCNJ2 mutation in one Taiwanese family with Andersen-Tawil syndrome. J Hum Genet 2010;55:186–188.
    OpenUrlCrossRefPubMed
  5. 5.↵
    1. Adzhubei IA,
    2. Schmidt S,
    3. Peshkin L, et al
    . A method and server for predicting damaging missense mutations. Nat Methods 2010;7:248–249.
    OpenUrlCrossRefPubMed
  6. 6.↵
    1. Haruna Y,
    2. Kobori A,
    3. Makiyama T, et al
    . Genotype-phenotype correlations of KCNJ2 mutations in Japanese patients with Andersen-Tawil syndrome. Hum Mutat 2007;28:208.
    OpenUrlCrossRefPubMed
  7. 7.↵
    1. Soom M,
    2. Schonherr R,
    3. Kubo Y,
    4. Kirsch C,
    5. Klinger R,
    6. Heinemann SH
    . Multiple PIP2 binding sites in Kir2.1 inwardly rectifying potassium channels. FEBS Lett 2001;490:49–53.
    OpenUrlCrossRefPubMed

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
  • Article
    • Study funding
    • Disclosure
    • Appendix 1 Author contributions
    • Footnotes
    • References
  • Figures & Data
  • Info & Disclosures
Advertisement

Preferences and User Experiences of Wearable Devices in Epilepsy A Systematic Review and Mixed-Methods Synthesis

Dr. Daniel Friedman and Dr. Sharon Chiang

► Watch

Related Articles

  • No related articles found.

Topics Discussed

  • All Genetics
  • All Pediatric
  • Muscle disease

Alert Me

  • Alert me when eletters are published
Neurology Genetics: 9 (2)

Articles

  • Articles
  • Issues
  • Popular Articles

About

  • About the Journals
  • Ethics Policies
  • Editors & Editorial Board
  • Contact Us
  • Advertise

Submit

  • Author Center
  • Submit a Manuscript
  • Information for Reviewers
  • AAN Guidelines
  • Permissions

Subscribers

  • Subscribe
  • Sign up for eAlerts
  • RSS Feed
Site Logo
  • Visit neurology Template on Facebook
  • Follow neurology Template on Twitter
  • Visit Neurology on YouTube
  • Neurology
  • Neurology: Clinical Practice
  • Neurology: Education
  • Neurology: Genetics
  • Neurology: Neuroimmunology & Neuroinflammation
  • AAN.com
  • AANnews
  • Continuum
  • Brain & Life
  • Neurology Today

Wolters Kluwer Logo

Neurology: Genetics | Online ISSN: 2376-7839

© 2023 American Academy of Neurology

  • Privacy Policy
  • Feedback
  • Advertise